NASCUM-VIREX Trademark
Serial Number: 79307156 • Registration: 6617331
NASCUM-VIREX is a trademark filed by
M et P Pharma AG
on February 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
February 2, 2021
Registration Date
January 18, 2022
Published for Opposition
November 2, 2021
Goods & Services
Medicated oleogel for nasal application for use of brain acting molecules effecting in the systemic circulation, brain, and spinal cord, as well as for trapping airborne particulate matter and preventing respiration of pollutants
Filing History
NEW REPRESENTATIVE AT IB RECEIVED
Jan 27, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 18, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 29, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 29, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 18, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 18, 2022 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 10, 2021 ADCH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
REFUSAL PROCESSED BY IB
Oct 4, 2021 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 29, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 28, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 27, 2021 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 11, 2021 RFCS
REFUSAL PROCESSED BY MPU
Sep 11, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 2, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 1, 2021 CNRT
CHANGE OF OWNER RECEIVED FROM IB
Aug 27, 2021 CHLD
ASSIGNED TO EXAMINER
Aug 24, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 30, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 25, 2021 REPR
